🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

European Multicentre Study of Human Spinal Cord Injury

Recruitingn/aAges 18 Years - anyAllUniversity of Zurich
NCT01571531 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Today there is accumulating evidence from animal experiments that regeneration can be induced after a spinal cord injury (SCI). Consequently in the near future, new therapeutic approaches to induce some regeneration will be included in the treatment of patients with SCI. The aim of this proposal is to provide the required clinical basis for the implementation of novel interventional therapies. The establishment of combined clinical, functional and neurophysiological measures for a qualitative and quantitative assessment of spinal cord function in patients with SCI at different stages during rehabilitation represents a basic requirement to monitor any significant effect of a new treatment. Therefore, several European Paraplegic Centres involved in the rehabilitation of acute traumatic SCI patients build up a close collaboration for standardised assessment. The aim is to get knowledge abou

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Single event traumatic or ischemic para- or tetraplegia * First EMSCI assessment possible within the first 6 weeks after incidence * Patient capable and willing of giving written informed consent Exclusion Criteria: * Nontraumatic para- or tetraplegia (i.e. discusprolaps, tumor, AV-malformation, myelitis) excl. single event ischemic incidences * Pre-known dementia or severe reduction of intelligence, leading to reduced capabilities of cooperation or giving consent * Peripheral nerve lesions above the level of lesion (i.e. plexus brachialis impairment) * Pre-known polyneuropathy * Severe craniocerebral injury
💊

What it tests

  • Not listed
📍

Where

1 site
University of Zurich
Zurich, Switzerland
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy